Cabazitaxel (Jevtana)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Cabazitaxel (Jevtana), covering 2017-01-24 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer [Phase 2]